Recombinant Anti-Kir2.1/KCNJ2 antibody [S112] (ab85492)
Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Mouse monoclonal [S112] to Kir2.1/KCNJ2
- Suitable for: WB, ICC/IF, IHC-P, Flow Cyt
- Reacts with: Mouse, Human, African green monkey
Overview
-
Product name
Anti-Kir2.1/KCNJ2 antibody [S112]
See all Kir2.1/KCNJ2 primary antibodies -
Description
Mouse monoclonal [S112] to Kir2.1/KCNJ2 -
Host species
Mouse -
Specificity
No cross reactivity against Kir2.2, or Kir2.3 -
Tested applications
Suitable for: WB, ICC/IF, IHC-P, Flow Cytmore details -
Species reactivity
Reacts with: Mouse, Human, African green monkey -
Immunogen
This product was produced with the following immunogens:
Recombinant fragment within Mouse Kir2.1/KCNJ2 aa 1-100. The exact immunogen sequence used to generate this antibody is proprietary information. If additional detail on the immunogen is needed to determine the suitability of the antibody for your needs, please contact our Scientific Support team to discuss your requirements.
Database link: P35561
Fusion protein corresponding to Mouse Kir2.1/KCNJ2 aa 189-428.
Database link: P35561 -
Positive control
- Rat brain normal tissue lysate - membrane extract (ab29473) can be used as a positive control in WB. Flow Cyt: SH-SY5Y cells. IHC-P: Human hippocampal tissue. ICC/IF: SK-N-SH cells.
-
General notes
The clone number has been updated from S112B-14 to N112B/14, both clone numbers name the same antibody clone.
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles. -
Storage buffer
Preservative: 0.09% Sodium azide
Constituents: PBS, 50% Glycerol -
Concentration information loading...
-
Purity
Protein G purified -
Clonality
Monoclonal -
Clone number
S112 -
Isotype
IgG1 -
Research areas
Associated products
-
Compatible Secondaries
-
Isotype control
-
Positive Controls
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab85492 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
WB |
Use a concentration of 1 µg/ml. Predicted molecular weight: 48 kDa.
If bands are weak, use lysate without boiling, heat at 37°C for 15 minutes. |
|
ICC/IF |
Use a concentration of 1 - 10 µg/ml.
|
|
IHC-P |
Use at an assay dependent concentration.
|
|
Flow Cyt |
Use 1-2µg for 106 cells.
ab170190 - Mouse monoclonal IgG1, is suitable for use as an isotype control with this antibody. |
Notes |
---|
WB
Use a concentration of 1 µg/ml. Predicted molecular weight: 48 kDa. If bands are weak, use lysate without boiling, heat at 37°C for 15 minutes. |
ICC/IF
Use a concentration of 1 - 10 µg/ml. |
IHC-P
Use at an assay dependent concentration. |
Flow Cyt
Use 1-2µg for 106 cells. ab170190 - Mouse monoclonal IgG1, is suitable for use as an isotype control with this antibody. |
Target
-
Function
Probably participates in establishing action potential waveform and excitability of neuronal and muscle tissues. Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages. The inward rectification is mainly due to the blockage of outward current by internal magnesium. Can be blocked by extracellular barium or cesium. -
Tissue specificity
Heart, brain, placenta, lung, skeletal muscle, and kidney. Diffusely distributed throughout the brain. -
Involvement in disease
Defects in KCNJ2 are the cause of long QT syndrome type 7 (LQT7) [MIM:170390]; also called Andersen syndrome or Andersen cardiodysrhythmic periodic paralysis. Long QT syndromes are heart disorders characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to excercise or emotional stress. LQT7 manifests itself as a clinical triad consisting of potassium-sensitive periodic paralysis, ventricular ectopy and dysmorphic features.
Defects in KCNJ2 are the cause of short QT syndrome type 3 (SQT3) [MIM:609622]. Short QT syndromes are heart disorders characterized by idiopathic persistently and uniformly short QT interval on ECG in the absence of structural heart disease in affected individuals. They cause syncope and sudden death. SQT3 has a unique ECG phenotype characterized by asymmetrical T waves. -
Sequence similarities
Belongs to the inward rectifier-type potassium channel (TC 1.A.2.1) family. KCNJ2 subfamily. -
Cellular localization
Membrane. - Information by UniProt
-
Database links
- Entrez Gene: 3759 Human
- Entrez Gene: 16518 Mouse
- Omim: 600681 Human
- SwissProt: P63252 Human
- SwissProt: P35561 Mouse
- Unigene: 1547 Human
- Unigene: 4951 Mouse
-
Alternative names
- Cardiac inward rectifier potassium channel antibody
- HHBIRK 1 antibody
- HHBIRK1 antibody
see all
Images
-
Anti-Kir2.1/KCNJ2 antibody [S112] (ab85492) at 1/1000 dilution + Monkey COS transient cell lysate at 15 µg with 1.5% BSA for 30 minutes at RT
Secondary
Sheep Anti-Mouse IgG: HRP for 1 hour at RT.
Predicted band size: 48 kDa -
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Kir2.1/KCNJ2 antibody [S112] (ab85492)
ab85492 staining Kir2.1/KCNJ2 in mouse backskin tissue by IHC-P (Bouin's fixed paraffin embedded).
Incubated with primary antibody at 1:1000 for 1 hour at RT. Secondary Antibody: FITC Goat Anti-Mouse (green) at 1:50 for 1 hour at RT.
-
ICC/IF image of ab85492 stained SK-N-SH (Human neuroblastoma cell line) cells.
The cells were 4% formaldehyde fixed (10 minutes) and then incubated in 1% BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1 hour to permeabilize the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab85492, 10 µg/ml) overnight at +4°C. The secondary antibody (green) was ab96879, DyLight® 488 goat anti-mouse IgG (H+L) used at a 1/250 dilution for 1 hour. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1 hour. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43 µM.
-
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Kir2.1/KCNJ2 antibody [S112] (ab85492)
ab85492 staining Kir2.1/KCNJ2 in human hippocampal tissue by IHC-P (Bouin's fixed paraffin embedded).
Incubated with primary antibody at 1:1000 for 1 hour at RT. Secondary Antibody: FITC Goat Anti-Mouse (green) at 1:50 for 1 hour at RT.
-
Overlay histogram showing SH-SY5Y (Human neuroblastoma cell line from bone marrow) cells stained with ab85492 (red line).
The cells were fixed with 80% methanol (5 minutes) and then permeabilized with 0.1% PBS-Tween for 20 minutes. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab85492, 1 µg/1x106 cells) for 30 minutes at 22ºC. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 minutes at 22ºC. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2 µg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive result in SH-SY5Y cells fixed with 4% paraformaldehyde (10 minutes)/permeabilized in 0.1% PBS-Tween for 20 minutes used under the same conditions.
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
Datasheets and documents
-
SDS download
-
Datasheet download
References (7)
ab85492 has been referenced in 7 publications.
- Fan L et al. Effects of Ruanmailing in Blocking Early Stages of Atherosclerosis by TNF-α Regulation via Kir2.1. Evid Based Complement Alternat Med 2022:2836880 (2022). PubMed: 35432558
- Chang C et al. Glycogen synthase kinase 3 beta inhibitor SB216763 improves Kir2.1 expression after myocardia infraction in rats. J Interv Card Electrophysiol N/A:N/A (2021). PubMed: 33611692
- Shi Y et al. Kir2.1 Channel Regulation of Glycinergic Transmission Selectively Contributes to Dynamic Mechanical Allodynia in a Mouse Model of Spared Nerve Injury. Neurosci Bull 35:301-314 (2019). PubMed: 30203408
- Binda A et al. A Novel KCNJ2 Mutation Identified in an Autistic Proband Affects the Single Channel Properties of Kir2.1. Front Cell Neurosci 12:76 (2018). PubMed: 29615871
- Ji CD et al. Kir2.1 Interaction with Stk38 Promotes Invasion and Metastasis of Human Gastric Cancer by Enhancing MEKK2-MEK1/2-ERK1/2 Signaling. Cancer Res 78:3041-3053 (2018). PubMed: 29549164
- Kamikawa A et al. Decrease in an Inwardly Rectifying Potassium Conductance in Mouse Mammary Secretory Cells after Forced Weaning. PLoS One 10:e0141131 (2015). WB ; Mouse . PubMed: 26484867
- Goldoni D et al. A novel dual-fluorescence strategy for functionally validating microRNA targets in 3-prime untranslated regions: regulation of the inward rectifier potassium channel Kir2.1 by miR-212. Biochem J : (2012). WB ; Human . PubMed: 22880819